Literature DB >> 19317515

Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers.

Steven G Carmella1, Menglan Chen, Shaomei Han, Anna Briggs, Joni Jensen, Dorothy K Hatsukami, Stephen S Hecht.   

Abstract

We determined the persistence at various times (3, 7, 14, 21, 28, 42, and 56 days) of eight tobacco smoke carcinogen and toxicant biomarkers in the urine of 17 smokers who stopped smoking. The biomarkers were 1-hydroxy-2-(N-acetylcysteinyl)-3-butene (1) and 1-(N-acetylcysteinyl)-2-hydroxy-3-butene (2) [collectively called MHBMA for monohydroxybutyl mercapturic acid] and 1,2-dihydroxy-4-(N-acetylcysteinyl)butane (3) [DHBMA for dihydroxybutyl mercapturic acid], metabolites of 1,3-butadiene; 1-(N-acetylcysteinyl)-propan-3-ol (4, HPMA for 3-hydroxypropyl mercapturic acid), a metabolite of acrolein; 2-(N-acetylcysteinyl)butan-4-ol (5, HBMA for 4-hydroxybut-2-yl mercapturic acid), a metabolite of crotonaldehyde; (N-acetylcysteinyl)benzene (6, SPMA for S-phenyl mercapturic acid), a metabolite of benzene; (N-acetylcysteinyl)ethanol (7, HEMA for 2-hydroxyethyl mercapturic acid), a metabolite of ethylene oxide; 1-hydroxypyrene (8) and its glucuronides (1-HOP), metabolites of pyrene; and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (9) and its glucuronides (total NNAL), a biomarker of exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). These biomarkers represent some of the major carcinogens and toxicants in cigarette smoke: 1,3-butadiene, acrolein, crotonaldehyde, benzene, ethylene oxide, polycyclic aromatic hydrocarbons (PAH), and NNK. With the exception of DHBMA, levels of which did not change after cessation of smoking, all other biomarkers decreased significantly after 3 days of cessation (P < 0.001). The decreases in MHBMA, HPMA, HBMA, SPMA, and HEMA were rapid, nearly reaching their ultimate levels (81-91% reduction) after 3 days. The decrease in total NNAL was gradual, reaching 92% after 42 days, while reduction in 1-HOP was variable among subjects to about 50% of baseline. Since DHBMA did not change upon smoking cessation, there appear to be sources of this metabolite other than 1,3-butadiene. The results of this study demonstrate that the tobacco smoke carcinogen/toxicant biomarkers MHBMA, HPMA, HBMA, SPMA, HEMA, 1-HOP, and NNAL are related to smoking and are good indicators of the impact of smoking on human exposure to 1,3-butadiene, acrolein, crotonaldehyde, benzene, ethylene oxide, PAH, and NNK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317515      PMCID: PMC2704054          DOI: 10.1021/tx800479s

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  64 in total

1.  COMPONENTS OF CIGARETTE SMOKE WITH CILIARY-DEPRESSANT ACTIVITY. THEIR SELECTIVE REMOVAL BY FILTERS CONTAINING ACTIVATED CHARCOAL GRANULES.

Authors:  C J KENSLER; S P BATTISTA
Journal:  N Engl J Med       Date:  1963-11-28       Impact factor: 91.245

2.  Improved method for determination of 1-hydroxypyrene in human urine.

Authors:  Steven G Carmella; Ky-Anh Le; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-07       Impact factor: 4.254

3.  Biomarkers for assessing occupational exposures to 1,3-butadiene.

Authors:  R J Albertini; R J Sram; P M Vacek; J Lynch; M Wright; J A Nicklas; P J Boogaard; R F Henderson; J A Swenberg; A D Tates; J B Ward
Journal:  Chem Biol Interact       Date:  2001-06-01       Impact factor: 5.192

4.  Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry.

Authors:  Amir Sapkota; Rolf U Halden; Francesca Dominici; John D Groopman; Timothy J Buckley
Journal:  Chem Biol Interact       Date:  2006-01-19       Impact factor: 5.192

5.  Simultaneous determination of t,t-muconic, S-phenylmercapturic and S-benzylmercapturic acids in urine by a rapid and sensitive liquid chromatography/electrospray tandem mass spectrometry method.

Authors:  Anna Barbieri; Laura Sabatini; Antonio Accorsi; Aldo Roda; Francesco Saverio Violante
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

6.  Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.

Authors:  Steven G Carmella; Shaomei Han; Anne Fristad; Yiying Yang; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

7.  Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.

Authors:  Richard J Albertini; Radim J Srám; Pamela M Vacek; Jeremiah Lynch; Janice A Nicklas; Nico J van Sittert; Peter J Boogaard; Rogene F Henderson; James A Swenberg; Ad D Tates; Jonathan B Ward; Michael Wright; Marinel M Ammenheuser; Blanka Binkova; Walter Blackwell; Franz A de Zwart; Dean Krako; Jennifer Krone; Hendricus Megens; Petra Musilová; Gabriela Rajská; Asoka Ranasinghe; Judah I Rosenblatt; Pavel Rössner; Jiri Rubes; Linda Sullivan; Patricia Upton; Ailko H Zwinderman
Journal:  Res Rep Health Eff Inst       Date:  2003-06

8.  Development and validation of an isotope-dilution electrospray ionization tandem mass spectrometry method with an on-line sample clean-up device for the quantitative analysis of the benzene exposure biomarker S-phenylmercapturic acid in human urine.

Authors:  Lung-Cheng Lin; Yu-Chang Tyan; Tung-Sheng Shih; Yu-Chen Chang; Pao-Chi Liao
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

9.  Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions.

Authors:  E Roemer; R Stabbert; K Rustemeier; D J Veltel; T J Meisgen; W Reininghaus; R A Carchman; C L Gaworski; K F Podraza
Journal:  Toxicology       Date:  2004-01-15       Impact factor: 4.221

10.  Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry.

Authors:  N J van Sittert; P J Boogaard; G D Beulink
Journal:  Br J Ind Med       Date:  1993-05
View more
  86 in total

1.  1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers.

Authors:  Sungshim Lani Park; Srikanth Kotapati; Lynne R Wilkens; Maarit Tiirikainen; Sharon E Murphy; Natalia Tretyakova; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China.

Authors:  Thomas W Kensler; Derek Ng; Steven G Carmella; Menglan Chen; Lisa P Jacobson; Alvaro Muñoz; Patricia A Egner; Jian Guo Chen; Geng Sun Qian; Tao Yang Chen; Jed W Fahey; Paul Talalay; John D Groopman; Jian-Min Yuan; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2011-11-01       Impact factor: 4.944

3.  High throughput HPLC-ESI(-)-MS/MS methodology for mercapturic acid metabolites of 1,3-butadiene: Biomarkers of exposure and bioactivation.

Authors:  Srikanth Kotapati; Amanda Esades; Brock Matter; Chap Le; Natalia Tretyakova
Journal:  Chem Biol Interact       Date:  2015-02-26       Impact factor: 5.192

4.  Analysis of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers.

Authors:  Siyi Zhang; Silvia Balbo; Mingyao Wang; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2010-11-22       Impact factor: 3.739

5.  Proposed cutoff for identifying adult smokeless tobacco users with urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol: an aggregated analysis of NHANES 2007-2010 data.

Authors:  Israel T Agaku; Constantine I Vardavas; Gregory Connolly
Journal:  Nicotine Tob Res       Date:  2013-08-16       Impact factor: 4.244

6.  Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke.

Authors:  Peyton Jacob; Maciej L Goniewicz; Christopher M Havel; Suzaynn F Schick; Neal L Benowitz
Journal:  Chem Res Toxicol       Date:  2013-10-14       Impact factor: 3.739

7.  Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.

Authors:  Cindy M Chang; Selvin H Edwards; Aarthi Arab; Arseima Y Del Valle-Pinero; Ling Yang; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11-09       Impact factor: 4.254

8.  Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention.

Authors:  Gideon St Helen; Evangelia Liakoni; Natalie Nardone; Newton Addo; Peyton Jacob; Neal L Benowitz
Journal:  Cancer Prev Res (Phila)       Date:  2019-09-25

9.  Crotonaldehyde exposure in U.S. tobacco smokers and nonsmokers: NHANES 2005-2006 and 2011-2012.

Authors:  Pritha Bagchi; Nathan Geldner; B Rey deCastro; Víctor R De Jesús; Sang Ki Park; Benjamin C Blount
Journal:  Environ Res       Date:  2018-02-03       Impact factor: 6.498

10.  Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Maciej L Goniewicz; Christopher M Havel; Margaret Wilson Peng; Peyton Jacob; Delia Dempsey; Lisa Yu; Wioleta Zielinska-Danch; Bartosz Koszowski; Jan Czogala; Andrzej Sobczak; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.